The first antidepressant works well for some p eople and not for others, and the split is closer to even than most patients are told. Nobody mentions this when the prescription is written, so a medication that does not work tends to get read as a verdict on the depression rather than as one result among several.
A depression treatment psychiatrist reads it differently. The first attempt produced information, and that information narrows what comes next. Here is how the decision actually gets made.
Before Anything Changes: Was the Trial Adequate
The first question is not what to try next. It is if the current medication was genuinely tested.
An adequate trial means a therapeutic dose taken consistently for six to eight weeks. A surprising number of apparent failures do not meet that standard. Stopping in week two because of side effects ends the trial before any benefit could appear, since most antidepressants take four to six weeks to show a full effect. Staying on the starting dose is another common shortfall, because that dose is frequently set below the level expected to work and exists mainly to reduce early side effects.
Inconsistent dosing matters too, and patients rarely volunteer it. Missing several doses a week changes the result, and it is worth saying plainly rather than leaving your psychiatrist to draw conclusions from incomplete information.
If the trial fell short in any of these ways, the correct next step is sometimes to complete it rather than abandon it.
Adjusting the Dose
When a medication has produced partial improvement, increasing the dose is usually the first move.
Partial response is a meaningfully different situation from no response. It indicates the medication is doing something, which makes it a reasonable candidate to do more. Abandoning it at that point discards useful ground and starts the six to eight week clock over with something unproven.
Dose increases happen gradually, with the same attention to side effects that applied at the start. Some people tolerate a higher dose without difficulty. Others find the side effects outweigh the additional benefit, and that outcome is informative in its own right.
Switching Medications
When there has been no meaningful change at an adequate dose over an adequate period, switching becomes the reasonable option.
There are two directions. Switching within the same class means trying another SSRI, which sounds pointless and is not. Two SSRIs are not interchangeable, and people respond differently to each despite similar mechanisms. Switching across classes opens more ground, moving to an SNRI, bupropion, mirtazapine, or another option.
The choice is driven partly by which symptoms dominate. Someone whose main problem is exhaustion, low motivation, and difficulty concentrating is usually directed differently than someone whose main problem is agitation, racing thoughts, and insomnia. Side effect profiles factor in as well, since a medication that causes sedation may suit one person and be intolerable for another.
Switching is done by cross-tapering rather than stopping one drug and starting another the next day. Your psychiatrist will explain the schedule, and following it matters.
Adding a Second Medication
Augmentation keeps the existing antidepressant in place and adds something alongside it. This is standard practice rather than a last resort, and it is often the right answer when there has been partial response that a dose increase did not extend.
The logic is straightforward. If a medication is working halfway, removing it to try something else forfeits the half that is working. Adding to it preserves that ground while targeting what remains.
Several categories of medication are used this way, and the choice depends on the residual symptoms and your medical history. As with any change, your psychiatrist should walk through the reasoning, the expected benefit, and the side effects before anything is prescribed.
What Else Gets Reconsidered
Persistent non-response is one of the main reasons a diagnosis gets revisited, and the review sometimes produces a different answer.
Bipolar depression is the most consequential possibility. Depressive episodes that are part of a bipolar illness often respond poorly to antidepressants alone, so a review of past periods of unusually high mood, reduced need for sleep, or increased activity is a routine part of the reassessment.
Other explanations surface regularly. Thyroid dysfunction produces depressive symptoms, as do sleep apnea and chronic sleep deprivation from any cause. Untreated ADHD in adults is frequently mistaken for depression, since years of underperformance relative to ability produces something that looks very similar. Alcohol interferes with both mood and medication. In women, symptoms that track the menstrual cycle, the postpartum period, or perimenopause point toward a hormonal component that changes the treatment plan.
Why Appointment Timing Matters Here
Every decision above depends on being seen while the relevant information is fresh.
This is why follow-up appointments cluster closely after a medication starts or changes, often every two to four weeks, then spread out once things are stable. The alternative is familiar and avoidable. Someone starts a medication, cannot get seen for three months, feels worse in week two, stops taking it, and arrives at the eventual appointment with the medication recorded as ineffective when it was never given a chance.
Keeping brief notes between appointments helps more than people expect. Depression distorts recall toward the negative, so comparing week one to week six from memory is unreliable. A few words a day gives an accurate comparison.
What to Expect from the Process
Most people who do not respond to a first antidepressant respond to a second, a third, or a combination. Response rates hold up across subsequent attempts, which is the part worth knowing while you are in the middle of it.
The stretch between a failed medication and a working one is discouraging in a specific way, since depression already argues that nothing will help and a medication that did not work feels like confirmation. That argument is more persuasive than the evidence supports.
Anyone whose depression is worsening during this period, or who is having thoughts of harming themselves, should raise it immediately rather than waiting for a scheduled appointment. In the United States, calling or texting 988 reaches the Suicide and Crisis Lifeline at any hour.